Alzheimer's Disease
Showing NaN - NaN of 77
Alzheimer's Disease Trial in Canada, United States (ELND005 (scyllo-inositol))
Completed
- Alzheimer's Disease
- ELND005 (scyllo-inositol)
-
Phoenix, Arizona
- +37 more
Oct 17, 2019
Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)
Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)
Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)
Alzheimer's Disease Trial in Canada, United States (AZD0530 100mg daily, AZD0530 125mg daily, Placebo)
Completed
- Alzheimer's Disease
- AZD0530 100mg daily
- +2 more
-
Phoenix, Arizona
- +21 more
Jul 25, 2019
Alzheimer's Disease Trial in New Haven (123-I MNI-340)
Terminated
- Alzheimer's Disease
- 123-I MNI-340
-
New Haven, ConnecticutThe Institute for Neurodegenerative Disorders
Apr 1, 2019
Alzheimer's Disease Trial in New Haven (I-123-MNI-168, 123-I MNI-168)
Terminated
- Alzheimer's Disease
- I-123-MNI-168
- 123-I MNI-168
-
New Haven, ConnecticutInstitute for Neurodegenerative Disorders
Apr 1, 2019
Alzheimer's Disease Trial in New Haven (I123MNI388/I123MNI390)
Terminated
- Alzheimer's Disease
-
New Haven, ConnecticutInstitute for Neurodegenerative Disorders
Apr 1, 2019
Alzheimer's Disease Trial in Worldwide (TRx0237 150 mg/day, TRx0237 250 mg/day, Placebo)
Completed
- Alzheimer's Disease
- TRx0237 150 mg/day
- +2 more
-
Phoenix, Arizona
- +120 more
Mar 12, 2018
Alzheimer's Disease Trial in Worldwide (TRx0237 200 mg/day, Placebo)
Completed
- Alzheimer's Disease
- TRx0237 200 mg/day
- Placebo
-
Phoenix, Arizona
- +94 more
Mar 12, 2018
Alzheimer's Disease Trial in Worldwide (Rosiglitazone Extended Release 2mg, Rosiglitazone Extended Release 8mg, Placebo)
Completed
- Alzheimer's Disease
- Rosiglitazone Extended Release 2mg
- +3 more
-
Litchfield Park, Arizona
- +248 more
Oct 23, 2017
Alzheimer's Disease Trial in Worldwide (Rosiglitazone XR)
Terminated
- Alzheimer's Disease
- Rosiglitazone XR
-
Litchfield Park, Arizona
- +271 more
Oct 11, 2017
Alzheimer's Disease Trial in Worldwide (PF-05212377 (SAM-760), Placebo)
Terminated
- Alzheimer's Disease
- PF-05212377 (SAM-760)
- Placebo
-
Costa Mesa, California
- +59 more
Jan 30, 2017
Alzheimer's Disease Trial in New Haven ([123I]MNI-672 SPECT)
Completed
- Alzheimer's Disease
- [123I]MNI-672 SPECT
-
New Haven, ConnecticutMolecular NeuroImaging, LLC
Dec 15, 2016